The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era

Table 3

Predictors of early TLR.

Clinical Factors	Adjusted Hazard Ratio	95% CI	P
Age (years old)	0.96	0.92-1.00	0.070
BMI (≥23kg/m^2)	0.78	0.37-1.61	0.494
Gender (male)	0.58	0.26-1.30	0.187
Previous PCI	2.41	1.03-5.65	0.043
Diabetes mellitus	2.58	1.29-5.15	0.007
Hypertension	0.70	0.31-1.60	0.397
CRF	2.37	0.94-5.98	0.068
Dyslipidemia	0.56	0.27-1.14	0.108
Current smoking	0.92	0.37-2.30	0.858
FHx of CAD	0.98	0.35-2.71	0.967
LV dysfunction (<40%)	2.01	0.41-9.76	0.387
Multivessel disease	1.20	0.52-2.81	0.669
Hemoglobin (g/dl)	0.94	0.77-1.16	0.586
CRP (mg/dl)	1.03	0.73-1.44	0.889
Type B2/C lesion	1.46	0.64-3.37	0.371
Reference vessel diameter (mm)	0.77	0.44-1.35	0.366
Lesion length (mm)	0.99	0.97-1.01	0.208
Pre-procedure DS (%)	1.01	0.98-1.04	0.546
Post-procedure DS%, in- stent (mm)	1.08	1.05-1.11	<0.001

TLR, target lesion revascularization; CI, confidence interval; BMI, body mass index; PCI, percutaneous coronary intervention; CRF, chronic renal failure; FHx, family history; CAD, coronary artery disease; LV, left ventricle; CRP, C-reactive protein; DS, diameter stenosis.